Biomx Inc logo

PHGE - Biomx Inc News Story

$5.92 0.3  5.0%

Last Trade - 18/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £250.7m
Enterprise Value £210.9m
Revenue £n/a
Position in Universe 3949th / 6846

BRIEF-Biomx Reports Phase 2 Study Of Newly Selected Phage Cocktail Candidate Bx005 In Atopic Dermatitis Expected To Initiate In H2 2021

Wed 31st March, 2021 11:47am
March 31 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * BIOMX - PHASE 2 PROOF-OF-CONCEPT CLINICAL STUDY OF NEWLY
SELECTED PHAGE COCKTAIL CANDIDATE, BX005, IN ATOPIC DERMATITIS
EXPECTED TO INITIATE IN H2 2021
    * BIOMX - EXISTING CASH, CASH EQUIVALENTS, SHORT-TERM
DEPOSITS
SUFFICIENT TO FUND CURRENT OPERATING PLAN, CAPITAL EXPENDITURE
REQUIREMENTS THROUGH MID-2022

Source text for Eikon:  ID:nBw1fkzsla 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.